# TEVA PHARMACEUTICAL INDUSTRIES LTD stock analysis

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-pot

## Market evidence and data freshness

The public preview recorded TEVA PHARMACEUTICAL INDUSTRIES LTD at 41.845 USD on 2026-11-05T19:08:44.000Z and marked the quote as delayed. This observation is not a trading signal.
Available price history spans 2021-11-08 through 2026-11-03 across 878 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

## What should I review before buying TEVA PHARMACEUTICAL INDUSTRIES LTD stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

## Inside the full report

- Valuation
- Growth
- Financial health
- Ownership
- Research

Sign in to open the full analysis. Paid plans use included reports first, then your weekly usage limit. Access lasts 72 hours, including revisits.

[Read the report](https://commonquant.ai/markets/teva)